Physician

Mark M. Radziewicz, D.O.

According to 2025 Medicare claims, Mark Radziewicz, D.O. (NPI: 1578528410) practices osteopathic manipulative therapy in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Luzerne, PA. This provider's primary affiliated billing organization is ADVANCED INPATIENT MEDICINE LEHIGH PC (NPI: 1437537875; TIN: 473880661) and primary practice location at 18201-6835. Radziewicz is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Radziewicz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 775 traditional Medicare patients, billed 3,477 HCPCS/CPT codes, and received $311,222 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,081 prescription claims across 399 beneficiaries totaling $220,180 in drug costs, led by Eliquis (Apixaban). DME data shows 225 claims. Open Payments data shows 4 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $299,520 and ending at $311,222. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $58,311 and ending at $220,180. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $12,207 and ending at $10,024.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	973	3,643	$299,520
2016	1,095	3,534	$284,360
2017	1,122	4,336	$361,512
2018	743	2,774	$204,180
2019	723	3,316	$283,050
2020	682	3,258	$270,797
2021	543	2,994	$252,687
2022	467	2,711	$206,290
2023	471	3,151	$268,963
2024	775	3,477	$311,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	268	1,540	$58,311
2016	353	2,588	$109,542
2017	489	6,707	$386,141
2018	557	6,460	$441,763
2019	439	1,751	$143,214
2020	397	1,916	$189,813
2021	402	1,908	$197,323
2022	398	2,497	$241,366
2023	411	3,203	$351,631
2024	399	2,081	$220,180

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	204	$8,518
2016	N/R	202	$7,288
2017	23	328	$8,310
2018	42	316	$8,909
2019	43	347	$9,313
2020	77	460	$14,229
2021	70	370	$14,066
2022	44	323	$12,734
2023	47	404	$14,535
2024	36	225	$8,920

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	288	309	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	510	1,746	$92
99239	Hospital discharge day management, more than 30 minutes	364	417	$89
99238	Hospital discharge day management, 30 minutes or less	138	151	$63
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	139	505	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	85	2,048	$39,705
Jardiance	Empagliflozin	52	1,535	$30,298
Entresto	Sacubitril/Valsartan	70	1,487	$29,222
Xarelto	Rivaroxaban	21	813	$15,892
Tradjenta	Linagliptin	17	690	$11,058

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	20	110	$7,366
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	16	80	$1,385
E0570	Nebulizer, with compressor	Y	N/R	35	$168

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$73	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark M. Radziewicz, D.O.?

Tedicare shows public-source Medicare data for Mark M. Radziewicz, D.O. (NPI 1578528410), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark M. Radziewicz, D.O. have ACO affiliation data?

Mark M. Radziewicz, D.O. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Mark M. Radziewicz, D.O.?

Mark M. Radziewicz, D.O. is linked to ADVANCED INPATIENT MEDICINE LEHIGH PC (billing NPI 1437537875) in the available physician profile data.

Does Mark M. Radziewicz, D.O. have Open Payments data?

Mark M. Radziewicz, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.